Tag: youngAge

Articles

• Birth control pill use and breast cancer
• BRCA1 and BRCA2 mutation carriers
• Breast cancer in very young women
• Breast density and breast cancer risk and recurrence
• Family history means higher risk and getting cancer at a younger age
• Foods to eat and avoid for ER-/PR+ patients and survivors
• HPV and breast cancer
• Triple negative breast cancer characteristics
• Triple negative breast cancer prognosis according to age at diagnosis
• Young breast cancer survivors can reduce risk of recurrence

News

10/21/24

Binge drinking linked to early ER+/PR+ breast cancer

07/22/17

ER+ can have worse prognosis than ER- disease in young women

12/09/14

Premenopausal African-American women experience worse BC outcomes

03/25/13

Non-BRCA carriers in BRCA families may get BC at younger age

08/12/12

Lymph node negative ER-/PR- BC has less favorable prognosis

01/10/12

Father's breast cancer or BRCA mutation influences daughter's risk

11/02/11

Even three alcoholic drinks per week increases risk of breast cancer

10/22/11

Young breast cancer patients require aggressive treatment

10/20/11

Age and breast cancer subtype influence prognosis after lumpectomy

08/05/11

Mexican breast cancer patients are younger & more likely to have TN BC

05/25/11

Tall girls have elevated risk of benign breast disease in adulthood

03/22/10

Breast reduction surgery may be combined with lumpectomy for DCIS

02/22/10

Benign breast disease less likely to progress if having children young

Studies

• The influence of treatment intervals on prognosis in young breast cancer patients: Insights from the French National cohort Cite
  Laas E, Dumas E, Hamy A, Gaillard T, Gougis P, Reyal F, et al. The influence of treatment intervals on prognosis in young breast cancer patients: Insights from the French National cohort. European Journal of Surgical Oncology. Elsevier BV; 2025; 51:109373 10.1016/j.ejso.2024.109373
• Age and Late Recurrence in Young Patients With ER–Positive, ERBB2-Negative Breast Cancer Cite
  Shin DS, Lee J, Kang E, Noh D, Cheun J, Lee J, et al. Age and Late Recurrence in Young Patients With ER–Positive, ERBB2-Negative Breast Cancer. JAMA Network Open. American Medical Association (AMA); 2024; 7:e2442663 10.1001/jamanetworkopen.2024.42663
• Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study Cite
  Christensen MH, Vinter CA, Olesen TB, Petersen MH, Nohr EA, Rubin KH, et al. Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01908-4
• Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years Cite
  Kehm RD, Genkinger JM, Knight JA, Maclnnis RJ, Liao Y, Li S, et al. Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 10.1158/1055-9965.epi-24-0743
• Increasing rates of early-onset Luminal A breast cancers correlate with binge drinking patterns Cite
  Chen J, Kehm R, Yang W, Terry MB. Increasing rates of early-onset Luminal A breast cancers correlate with binge drinking patterns. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01894-7
• Breastfeeding experiences among young breast cancer survivors: A survey study Cite
  Sella T, Sorouri K, Rosenberg SM, Loucks M, Kirkner G, Snow C, et al. Breastfeeding experiences among young breast cancer survivors: A survey study. Cancer. Wiley; 2024; 10.1002/cncr.35585
• Abstract A029: Age at menarche and risk of young-onset breast cancer subtypes overall and by race/ethnicity and socioeconomic position Cite
  Zhang Z, Marcus Post LR, Pathak DR, Hamilton AS, Hirko KA, Houang R, et al. Abstract A029: Age at menarche and risk of young-onset breast cancer subtypes overall and by race/ethnicity and socioeconomic position. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 33:A029-A029 10.1158/1538-7755.disp24-a029
• Genetic Risk, Health-Associated Lifestyle, and Risk of Early-onset Total Cancer and Breast Cancer Cite
  Zhang Y, Lindström S, Kraft P, Liu Y. Genetic Risk, Health-Associated Lifestyle, and Risk of Early-onset Total Cancer and Breast Cancer. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2024; 10.1093/jnci/djae208
• Second primary malignancies in women with breast cancer Cite
  Chen C, Tseng J, Amersi F, Silberman AW. Second primary malignancies in women with breast cancer. Journal of Surgical Oncology. Wiley; 2024; 10.1002/jso.27785
• Hormone receptor-positive early breast cancer in young women: A comprehensive review Cite
  Walbaum B, García-Fructuoso I, Martínez-Sáez O, Schettini F, Sánchez C, Acevedo F, et al. Hormone receptor-positive early breast cancer in young women: A comprehensive review. Cancer Treatment Reviews. Elsevier BV; 2024;:102804 10.1016/j.ctrv.2024.102804
• Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development Cite
  Pilewskie M, Eroglu I, Sevilimedu V, Le T, Mangino D, Morrow M. Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2024; 10.1245/s10434-024-15633-x
• Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention Cite
  Dioun SM, Perez LR, Prabhu M, Brewer JT, Ahsan MD, Hou JY, et al. Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention. American Journal of Obstetrics and Gynecology. Elsevier BV; 2024; 10.1016/j.ajog.2024.04.014
• Contemporary Review of the Management and Treatment of Young Breast Cancer Patients Cite
  Vuong B, Jacinto AI, Chang SB, Kuehner GE, Savitz AC. Contemporary Review of the Management and Treatment of Young Breast Cancer Patients. Clinical Breast Cancer. Elsevier BV; 2024; 10.1016/j.clbc.2024.06.001
• Fertility among young breast cancer survivors attempting pregnancy: A prospective, multicentre cohort study. Cite
  Sorouri K, Zheng Y, Niman SM, Dibble K, Rosenberg SM, Kirkner GJ, et al. Fertility among young breast cancer survivors attempting pregnancy: A prospective, multicentre cohort study.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 42:1518-1518 10.1200/jco.2024.42.16_suppl.1518
• The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age Cite
  Boutrus RR, Abdelazim YA, Mohammed T, Bayomy M, Ibraheem MH, Hussein A, et al. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age. BMC Cancer. Springer Science and Business Media LLC; 2024; 24 10.1186/s12885-024-12325-3
• The distribution of breast density in women aged 18 years and older Cite
  Perera D, Pirikahu S, Walter J, Cadby G, Darcey E, Lloyd R, et al. The distribution of breast density in women aged 18 years and older. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07269-y
• Abstract PO3-11-10: Second primary non-breast cancers in young breast cancer survivors Cite
  Zhang B, Brantley K, Rosenberg S, Kirkner G, Collins L, Ruddy K, et al. Abstract PO3-11-10: Second primary non-breast cancers in young breast cancer survivors. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PO3-11-10-PO3-11-10 10.1158/1538-7445.sabcs23-po3-11-10
• Second Primary Breast Cancer in Young Breast Cancer Survivors Cite
  Brantley KD, Rosenberg SM, Collins LC, Ruddy KJ, Tamimi RM, Schapira L, et al. Second Primary Breast Cancer in Young Breast Cancer Survivors. JAMA Oncology. American Medical Association (AMA); 2024; 10.1001/jamaoncol.2024.0286
• The Relationship Between Breast Cancer Risk Factors and Mammographic Density Cite
  Ranjkesh M, Shaker S, Mehrtabar S, Ahmadpour Youshanlui M, Alihosseini S. The Relationship Between Breast Cancer Risk Factors and Mammographic Density. International Journal of Drug Research in Clinics. Maad Rayan Publishing Company; 2024; 2:e3 10.34172/ijdrc.2024.e3
• Survival Analysis of Young Triple-Negative Breast Cancer Patients Cite
  O MMO, Horestani FJ, Schwarz G. Survival Analysis of Young Triple-Negative Breast Cancer Patients. arXiv; 2024; 10.48550/ARXIV.2401.08712
• Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status Cite
  Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Network Open. American Medical Association (AMA); 2024; 7:e2353331 10.1001/jamanetworkopen.2023.53331
• Association of imaging and pathological findings of breast cancer in very young women: Report of a twenty-year retrospective study Cite
  Sefidbakht S, Beizavi Z, Nejad FK, Pishdad P, Sadighi N, Johari MG, et al. Association of imaging and pathological findings of breast cancer in very young women: Report of a twenty-year retrospective study. Clinical Imaging. Elsevier BV; 2024;:110094 10.1016/j.clinimag.2024.110094
• Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients Cite
  Vidarsdottir L, Olafsdottir EJ, Barkardottir RB, Bjarnadottir O, Jonasson JG, Sigurdsson S, et al. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00600-8
• Pregnancy After Breast Cancer in Young BRCA Carriers Cite
  Lambertini M, Blondeaux E, Agostinetto E, Hamy A, Kim HJ, Di Meglio A, et al. Pregnancy After Breast Cancer in Young BRCA Carriers. JAMA. American Medical Association (AMA); 2023; 10.1001/jama.2023.25463
• First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort Cite
  Galvin A, Courtinard C, Bouteiller F, Gourgou S, Dalenc F, Jacot W, et al. First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort. European Journal of Cancer. Elsevier BV; 2024; 196:113422 10.1016/j.ejca.2023.113422
• Lifetime alcohol consumption patterns and young-onset breast cancer by subtype among Non-Hispanic Black and White women in the Young Women’s Health History Study Cite
  Hirko KA, Lucas DR, Pathak DR, Hamilton AS, Post LM, Ihenacho U, et al. Lifetime alcohol consumption patterns and young-onset breast cancer by subtype among Non-Hispanic Black and White women in the Young Women’s Health History Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2023; 10.1007/s10552-023-01801-z
• Suboptimal use of ovarian function suppression in very young women with early breast cancer: a real-world data study Cite
  Heredia A, Walbaum B, Vidal M, Itriago L, Camus M, Dominguez F, et al. Suboptimal use of ovarian function suppression in very young women with early breast cancer: a real-world data study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07117-5
• Survivorship Navigation for Young Women With Early-Stage Breast Cancer Cite
  Knelson LP, Rosenberg S, Snow C, Rigby K, Lynch J, Sella T, et al. Survivorship Navigation for Young Women With Early-Stage Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2023; 10.1016/j.clbc.2023.07.009
• Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial Cite
  Baek SY, Noh WC, Ahn S, Kim H, Ryu JM, Kim SI, et al. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 10.1200/jco.23.00557
• Comparison of Survival Outcomes in Young Patients with Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy Cite
  Huang H, Wei T, Zhang A, Zhang H, Kong L, Li Y, et al. Comparison of Survival Outcomes in Young Patients with Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy. Clinical Breast Cancer. Elsevier BV; 2023; 10.1016/j.clbc.2023.07.010
• Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022 Cite
  Gremke N, Wagner U, Kalder M, Kostev K. Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07048-1
• Making sense of the risks: what to tell adolescents and young adults diagnosed with cancer during pregnancy Cite
  Nathan PC, Su HI. Making sense of the risks: what to tell adolescents and young adults diagnosed with cancer during pregnancy. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 115:603-604 10.1093/jnci/djad066
• Survival After Contralateral Secondary Breast Cancer by Age Group in California Cite
  Perry LM, Keegan THM, Li Q, Bold RJ, Antonino NF, Maguire FB, et al. Survival After Contralateral Secondary Breast Cancer by Age Group in California. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-13902-9
• Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial. Cite
  Ligibel JA, Ballman KV, McCall LM, Goodwin PJ, Weiss A, Delahanty L, et al. Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:12001-12001 10.1200/jco.2023.41.16_suppl.12001
• 276P Safety of pregnancy after early breast cancer in young women with hormone receptor-positive disease: A systematic review and meta-analysis Cite
  Arecco L, Blondeaux E, Bruzzone M, Latocca M, Mariamidze E, Begijanashvili S, et al. 276P Safety of pregnancy after early breast cancer in young women with hormone receptor-positive disease: A systematic review and meta-analysis. ESMO Open. Elsevier BV; 2023; 8:101372 10.1016/j.esmoop.2023.101372
• 157P Comparison of survival outcomes in young patients with breast cancer receiving contralateral prophylactic mastectomy versus unilateral mastectomy Cite
  Huang H. 157P Comparison of survival outcomes in young patients with breast cancer receiving contralateral prophylactic mastectomy versus unilateral mastectomy. ESMO Open. Elsevier BV; 2023; 8:101497 10.1016/j.esmoop.2023.101497
• Lived experiences of breast cancer in patients under age 40: A phenomenological study Cite
  Kim J, Lee K. Lived experiences of breast cancer in patients under age 40: A phenomenological study. European Journal of Oncology Nursing. Elsevier BV; 2023;:102336 10.1016/j.ejon.2023.102336
• Young age is associated with inferior outcomes in early-stage luminal B breast cancer patients who undergo mastectomy Cite
  Hou J, Li L, Wang J, Huang X, Xue J, Wu J. Young age is associated with inferior outcomes in early-stage luminal B breast cancer patients who undergo mastectomy. Future Oncology. Future Medicine Ltd; 2023; 19:715-726 10.2217/fon-2023-0083
• Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors Cite
  Sella T, Zheng Y, Rosenberg SM, Ruddy KJ, Gelber SI, Tamimi RM, et al. Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00529-y
• The association between age at breast cancer diagnosis and prevalence of pathogenic variants Cite
  Daly MB, Rosenthal E, Cummings S, Bernhisel R, Kidd J, Hughes E, et al. The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 199:617-626 10.1007/s10549-023-06946-8
• Prognosis after Local Recurrence in Patients with Early-Stage Breast Cancer Treated without Chemotherapy Cite
  Sopik V, Lim D, Sun P, Narod SA. Prognosis after Local Recurrence in Patients with Early-Stage Breast Cancer Treated without Chemotherapy. Current Oncology. MDPI AG; 2023; 30:3829-3844 10.3390/curroncol30040290
• The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Basmadjian RB, Chow K, Kim D, Kenney M, Lukmanji A, O’Sullivan DE, et al. The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Cancers. MDPI AG; 2023; 15:1923 10.3390/cancers15071923
• What Is Known about Breast Cancer in Young Women? Cite
  Zhu JW, Charkhchi P, Adekunte S, Akbari MR. What Is Known about Breast Cancer in Young Women?. Cancers. MDPI AG; 2023; 15:1917 10.3390/cancers15061917
• Approaches to Fertility Preservation for Young Women With Breast Cancer Cite
  Razeti MG, Soldato D, Arecco L, Levaggi A, Puglisi S, Solinas C, et al. Approaches to Fertility Preservation for Young Women With Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2023; 10.1016/j.clbc.2023.01.006
• Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers Cite
  Lewinsohn R, Zheng Y, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, et al. Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.12.012
• The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups Cite
  Zheng H, Ge C, Lin H, Zhou S, Tang W, Wang Q, et al. The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PLOS ONE. Public Library of Science (PLoS); 2023; 18:e0280474 10.1371/journal.pone.0280474
• Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis Cite
  Ochi T, Yoshida A, Takahashi O, Kajiura Y, Takei J, Hayashi N, et al. Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis. Breast Cancer. Springer Science and Business Media LLC; 2023; 10.1007/s12282-022-01429-y
• Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah Cite
  Zhang Z, Bassale S, Jindal S, Fraser A, Guinto E, Anderson W, et al. Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah. JAMA Network Open. American Medical Association (AMA); 2022; 5:e2236763 10.1001/jamanetworkopen.2022.36763
• Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ Cite
  Tesch ME, Rosenberg SM, Collins LC, Wong JS, Dominici L, Ruddy KJ, et al. Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 29:8048-8057 10.1245/s10434-022-12361-y
• Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis Cite
  Marklund A, Lekberg T, Hedayati E, Liljegren A, Bergh J, Lundberg FE, et al. Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis. JAMA Oncology. American Medical Association (AMA); 2022; 10.1001/jamaoncol.2022.3677
• Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study Cite
  Ihenacho U, Hamilton AS, Mack WJ, Wu AH, Unger JB, Pathak DR, et al. Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06675-4
• Varying outcomes of triple-negative breast cancer in different age groups - prognostic value of clinical features and proliferation Cite
  Vihervuori H, Korpinen K, Autere T, Repo H, Talvinen K, Kronqvist P. Varying outcomes of triple-negative breast cancer in different age groups - prognostic value of clinical features and proliferation. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1902788/v1
• Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis Cite
  Drapalik LM, Estes A, Sarode AL, Cao L, Shenk RR, Jarrett CM, et al. Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis. Surgery. Elsevier BV; 2022; 172:821-830 10.1016/j.surg.2022.05.026
• Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors Cite
  Von Ah D, Crouch AD, Monahan PO, Stump TE, Unverzagt FW, Storey S, et al. Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2021; 16:812-822 10.1007/s11764-021-01075-x
• Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery Cite
  Orozco JIJ, Keller JK, Chang S, Fancher CE, Grumley JG. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-12190-z
• Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy Cite
  Anderson RA, Lambertini M, Hall PS, Wallace WH, Morrison DS, Kelsey TW. Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy. European Journal of Cancer. Elsevier BV; 2022; 173:113-122 10.1016/j.ejca.2022.06.048
• Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors Cite
  Sella T, Zheng Y, Tan‐Wasielewski Z, Rosenberg SM, Poorvu PD, Tayob N, et al. Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors. Cancer. Wiley; 2022; 10.1002/cncr.34342
• Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics Cite
  Sheng D, Shen X, Shi Z, Chang C, Li J. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics. European Radiology. Springer Science and Business Media LLC; 2022; 10.1007/s00330-022-08910-4
• Fertility Considerations for Reproductive-Aged Carriers of Deleterious BRCA Mutations: A Call for Early Intervention Cite
  Fine E, Knoll MA, Maslow BL. Fertility Considerations for Reproductive-Aged Carriers of Deleterious BRCA Mutations: A Call for Early Intervention. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2022; 18:165-168 10.1200/op.21.00389
• Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis Cite
  zhang w, Liu J, Zhang X, Yang C, Cao M, Zhang S, et al. Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1434952/v1
• Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland Cite
  Montagna G, Schaffar R, Bordoni A, Spitale A, Terribile DA, Rossi L, et al. Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland. Cancers. MDPI AG; 2022; 14:1328 10.3390/cancers14051328
• Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort Cite
  Strandberg R, Czene K, Eriksson M, Hall P, Humphreys K. Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2022;:cebp.1011.2021 10.1158/1055-9965.epi-21-1011
• Disparities in timely treatment among young women with breast cancer Cite
  Jain U, Jain B, Fayanju OM, Chino F, Dee EC. Disparities in timely treatment among young women with breast cancer. The American Journal of Surgery. Elsevier BV; 2022; 10.1016/j.amjsurg.2022.01.019
• Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network Cite
  Puchar A, Despierres M, Boudy A, Selleret L, Gligorov J, Richard S, et al. Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network. The Breast. Elsevier BV; 2022; 61:168-174 10.1016/j.breast.2022.01.004
• Breast Cancer in Chinese Females Aged 25 Years and Younger Cite
  Li L, Lv D, Zhai J, Zhang D, Guan X, Ma F. Breast Cancer in Chinese Females Aged 25 Years and Younger. Journal of Oncology. Hindawi Limited; 2021; 2021:1-9 10.1155/2021/4891936
• Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer Cite
  Guay E, Cordeiro E, Roberts A. Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-11102-x
• Palpable multifocal and multicentric invasive lobular breast carcinoma in a young female Cite
  Qiu W, Hu TN. Palpable multifocal and multicentric invasive lobular breast carcinoma in a young female. Radiology Case Reports. Elsevier BV; 2022; 17:269-274 10.1016/j.radcr.2021.10.056
• Age Under 30 Years As a Predictor of Poor Survival in a Cohort of Mexican Women With Breast Cancer Cite
  Alvarez-Bañuelos MT, Segura-Jaramillo KA, Gómez-Rivera EdC, Alarcón-Rojas CA, Morales-Romero J, Sampieri CL, et al. Age Under 30 Years As a Predictor of Poor Survival in a Cohort of Mexican Women With Breast Cancer. Cancer Control. SAGE Publications; 2021; 28:107327482110474 10.1177/10732748211047408
• Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions Cite
  Sella T, Ruddy KJ, Carey LA, Partridge AH. Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2021; 10.1200/op.21.00482
• Reproductive history differs by molecular subtypes of breast cancer among women aged ≤50 years in Scotland in 2009-16: A population-based retrospective cohort study Cite
  Chitkara A, Mesa-Eguiagaray I, Wild SH, Hall PS, Cameron D, Figueroa J. Reproductive history differs by molecular subtypes of breast cancer among women aged ≤50 years in Scotland in 2009-16: A population-based retrospective cohort study. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-940729/v1
• 190P Clinical features and recurrence-free survival among young patients with breast cancer Cite
  Ferrigno A, Aranda-Gutierrez A, Becerril-Gaitan A, Vaca-Cartagena B, Gonzalez-Mondellini F, Acosta-Sandoval M, et al. 190P Clinical features and recurrence-free survival among young patients with breast cancer. Annals of Oncology. Elsevier BV; 2021; 32:S440 10.1016/j.annonc.2021.08.471
• 189P Invasive lobular carcinoma in young breast cancer patients: Incidence and clinicopathological characteristics Cite
  Omar A, Masoud H, Darwesh A. 189P Invasive lobular carcinoma in young breast cancer patients: Incidence and clinicopathological characteristics. Annals of Oncology. Elsevier BV; 2021; 32:S440 10.1016/j.annonc.2021.08.470
• Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period Cite
  Lefrère H, Floris G, Schmidt MK, Neven P, Warner E, Cardonick E, et al. Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period. Data in Brief. Elsevier BV; 2021; 38:107354 10.1016/j.dib.2021.107354
• Can Breast Implants Induce Breast Cancer Immunosurveillance? An Analysis of Antibody Response to Breast Cancer Antigen following Implant Placement Cite
  Fracol M, Shah N, Dolivo D, Hong S, Giragosian L, Galiano R, et al. Can Breast Implants Induce Breast Cancer Immunosurveillance? An Analysis of Antibody Response to Breast Cancer Antigen following Implant Placement. Plastic & Reconstructive Surgery. Ovid Technologies (Wolters Kluwer Health); 2021; 148:287-298 10.1097/prs.0000000000008165
• Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women Cite
  Evans DG, Howell SJ, Gandhi A, van Veen EM, Woodward ER, Harvey J, et al. Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06333-1
• The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy Cite
  Vrieling C, Assele SY, Moser L, Sauvé N, Litière S, Fourquet A, et al. The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy. European Journal of Cancer. Elsevier BV; 2021; 155:28-37 10.1016/j.ejca.2021.06.018
• Inflammatory Breast Cancer at the Extremes of Age Cite
  Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, et al. Inflammatory Breast Cancer at the Extremes of Age. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10453-9
• Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns Cite
  Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine. Elsevier BV; 2021; 38:100985 10.1016/j.eclinm.2021.100985
• Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, et al. Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021;:JCO.21.00535 10.1200/jco.21.00535
• Abstract 790: A Utah Population Data Base Study of young women's breast cancer outcomes by parity status Cite
  Schedin P, Jindal S, Bassale S, Zhang Z, Fraser A, Guinto E, et al. Abstract 790: A Utah Population Data Base Study of young women's breast cancer outcomes by parity status. Epidemiology. American Association for Cancer Research; 2021; 10.1158/1538-7445.am2021-790
• Breast cancer in young women: Imaging and clinical course Cite
  Langman EL, Kuzmiak CM, Brader R, Thomas SM, Alexander SL, Lee SS, et al. Breast cancer in young women: Imaging and clinical course. The Breast Journal. Wiley; 2021; 10.1111/tbj.14261
• Preoperative Breast MRI in Women 35 Years of Age and Younger with Breast Cancer: Benefits in Surgical Outcomes by Using Propensity Score Analysis Cite
  Park AR, Chae EY, Cha JH, Shin HJ, Choi WJ, Kim HH. Preoperative Breast MRI in Women 35 Years of Age and Younger with Breast Cancer: Benefits in Surgical Outcomes by Using Propensity Score Analysis. Radiology. Radiological Society of North America (RSNA); 2021;:204124 10.1148/radiol.2021204124
• Pesticide exposure and gender discrepancy in breast cancer Cite
  Ledda C, Bracci M, Lovreglio P, Senia P, Larrosa M, Martínez-Jarreta B, et al. Pesticide exposure and gender discrepancy in breast cancer. European Review for Medical and Pharmacological Sciences. Verduci Editore s.r.l.; 2021; 25:2898-2915. 10.26355/eurrev_202104_25543
• Comprehensive omic characterization of breast cancer in Mexican-Hispanic women Cite
  Romero-Cordoba SL, Salido-Guadarrama I, Rebollar-Vega R, Bautista-Piña V, Dominguez-Reyes C, Tenorio-Torres A, et al. Comprehensive omic characterization of breast cancer in Mexican-Hispanic women. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-021-22478-5
• Cyclophosphamide-free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women with Breast Cancer Cite
  Lambertini M, Partridge AH. Cyclophosphamide-free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women with Breast Cancer. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 10.1093/jnci/djab066
• Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data Cite
  Lailler G, Memoli V, Le Bihan Benjamin C, Ben Diane M, Lauzier S, Mancini J, et al. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.01.007
• Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation Cite
  Lefrère H, Lenaerts L, Borges VF, Schedin P, Neven P, Amant F. Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation. International Journal of Gynecologic Cancer. BMJ; 2021; 31:412-422 10.1136/ijgc-2020-002072
• Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone Cite
  Nguyen DV, Kim S, Oh Y, Noh OK, Jung Y, Yoon DS, et al. Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone. Research Square; 2021; 10.21203/rs.3.rs-209244/v1
• Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants Cite
  Lambertini M, Ceppi M, Hamy A, Caron O, Poorvu PD, Carrasco E, et al. Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00224-w
• Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966 Cite
  Tastula A, Jukkola A, Alakokkare A, Nordström T, Eteläinen S, Karihtala P, et al. Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1442.2020 10.1158/1055-9965.epi-20-1442
• Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years Cite
  Cathcart-Rake EJ, Ruddy KJ, Bleyer A, Johnson RH. Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2021;:OP.20.00793 10.1200/op.20.00793
• Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer Cite
  Goldfarb SB, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, et al. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05933-7
• 10-Year Breast Cancer Outcomes in Women ≤35 Years of Age Cite
  Billena C, Wilgucki M, Flynn J, Modlin L, Tadros A, Razavi P, et al. 10-Year Breast Cancer Outcomes in Women ≤35 Years of Age. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2020; 10.1016/j.ijrobp.2020.10.022
• Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy Cite
  Falco M, Masojć B, Kram A. Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy. The Breast Journal. Wiley; 2020; 26:2364-2370 10.1111/tbj.14118
• Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer Cite
  Sella T, Gelber SI, Poorvu PD, Kim H, Dominici L, Guzman-Arocho YD, et al. Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05989-5
• Presentation and characteristics of breast cancer in young women under age 40 Cite
  Hu X, Myers KS, Oluyemi ET, Philip M, Azizi A, Ambinder EB. Presentation and characteristics of breast cancer in young women under age 40. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-06000-x
• Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer Cite
  Turnbull AK, Patel S, Martinez-Perez C, Rigg A, Oikonomidou O. Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05951-5
• Choice of local therapy for young women with early‐stage breast cancer who have young‐aged children Cite
  Pan I, Yen TWF, Huo J, Chen C, Smith BD, Shih YT. Choice of local therapy for young women with early‐stage breast cancer who have young‐aged children. Cancer. Wiley; 2020; 126:4761-4769 10.1002/cncr.33099
• Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy Cite
  Ishitobi M, Matsuda N, Tazo M, Nakayama S, Tokui R, Ogawa T, et al. Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09176-0
• Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience Cite
  Bennett I, Tourani S, Cockburn L, Reasbeck J, Grobbelaar N, Dann S, et al. Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience. ANZ Journal of Surgery. Wiley; 2020; 10.1111/ans.16320
• Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ Cite
  Bandera BC, Voci A, Nelson DW, Stern S, Barrak D, Fischer TD, et al. Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ. Clinical Breast Cancer. Elsevier BV; 2020; 20:e397-e402 10.1016/j.clbc.2020.01.006
• Breast cancer in women younger than 35 years old Cite
  Zouzoulas D, Tsolakidis D, Gitas G, Zafrakas M, Goulis DG, Douganiotis G, et al. Breast cancer in women younger than 35 years old. Archives of Gynecology and Obstetrics. Springer Science and Business Media LLC; 2020; 302:721-730 10.1007/s00404-020-05695-z
• Breast cancer during pregnancy: matched study of diagnostic approach, tumor characteristics, and prognostic factors Cite
  Reyes E, Xercavins N, Saura C, Espinosa-Bravo M, Gil-Moreno A, Cordoba O. Breast cancer during pregnancy: matched study of diagnostic approach, tumor characteristics, and prognostic factors. Tumori Journal. SAGE Publications; 2020; 106:378-387 10.1177/0300891620925158
• Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation Cite
  Yeh JM, Lowry KP, Schechter CB, Diller LR, Alagoz O, Armstrong GT, et al. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation. Annals of Internal Medicine. American College of Physicians; 2020; 173:331-341 10.7326/m19-3481
• A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns Cite
  Tzikas A, Nemes S, Linderholm BK. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:643-654 10.1007/s10549-020-05727-x
• Breast cancer in the young patient: review of therapy and treatment considerations Cite
  Subhedar PD, McLaughlin SA. Breast cancer in the young patient: review of therapy and treatment considerations. Breast Cancer Management. Future Medicine Ltd; 2020; 9:BMT39 10.2217/bmt-2020-0008
• Risk factors of ipsilateral breast tumor recurrence in triple-negative or HER2-positive breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy. Cite
  Tazo M, Kojima Y, Yoshida A, Nakayama S, Tokui R, Ogawa T, et al. Risk factors of ipsilateral breast tumor recurrence in triple-negative or HER2-positive breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:e12599-e12599 10.1200/jco.2020.38.15_suppl.e12599
• The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer Cite
  van Barele M, Heemskerk-Gerritsen BA, van Doorn HC, Schmidt MK, Hooning MJ, Jager A. The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer. The Breast. Elsevier BV; 2020; 52:102-109 10.1016/j.breast.2020.05.004
• Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients Cite
  Ou JY, Hanson HA, Ramsay JM, Kaddas HK, Pope CA, Leiser CL, et al. Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:1929-1939 10.1158/1055-9965.epi-19-1363
• Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database Cite
  Fabiano V, Mandó P, Rizzo M, Ponce C, Coló F, Loza M, et al. Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database. JCO Global Oncology. American Society of Clinical Oncology (ASCO); 2020;:639-646 10.1200/jgo.19.00228
• Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom) Cite
  Renehan AG, Pegington M, Harvie MN, Sperrin M, Astley SM, Brentnall AR, et al. Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom). British Journal of Cancer. Springer Science and Business Media LLC; 2020; 122:1552-1561 10.1038/s41416-020-0807-9
• Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period Cite
  O’Sullivan CC, Irshad S, Wang Z, Tang Z, Umbricht C, Rosner GL, et al. Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:695-706 10.1007/s10549-020-05585-7
• Breast Lesions in Women Aged Younger than 30 Years: Clinical Presentation, Diagnosis, and Management Cite
  Clark HR, Merchant KA, Omar LA, Compton LM, Hayes JC. Breast Lesions in Women Aged Younger than 30 Years: Clinical Presentation, Diagnosis, and Management. Journal of Breast Imaging. Oxford University Press (OUP); 2020; 2:72-80 10.1093/jbi/wbz086
• Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer Cite
  Choi M, Han J, Yang BR, Jang M, Kim M, Kim T, et al. Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer. The Oncologist. Wiley; 2019; 24 10.1634/theoncologist.2019-0167
• Risk factors for locoregional recurrence (LRR) after neoadjuvant chemotherapy: Pooled analysis of prospective neoadjuvant breast cancer (BC) trials Cite
  Werutsky G, Untch M, Hanusch C, Fasching P, Blohmer J, Seiler S, et al. Risk factors for locoregional recurrence (LRR) after neoadjuvant chemotherapy: Pooled analysis of prospective neoadjuvant breast cancer (BC) trials. Annals of Oncology. Elsevier BV; 2019; 30:v62-v63 10.1093/annonc/mdz240.014
• Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women Cite
  Vande Walle K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, Fernandes-Taylor S, Schumacher JR, et al. Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:4310-4316 10.1245/s10434-019-07726-9
• A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland Cite
  Schaffar R, Bouchardy C, Chappuis PO, Bodmer A, Benhamou S, Rapiti E. A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland. PLOS ONE. Public Library of Science (PLoS); 2019; 14:e0222136 10.1371/journal.pone.0222136
• Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties Cite
  Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC. Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:3920-3930 10.1245/s10434-019-07653-9
• A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36–45 years) breast cancer patients Cite
  Szollár A, Újhelyi M, Polgár C, Oláh E, Pukancsik D, Rubovszky G, et al. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36–45 years) breast cancer patients. European Journal of Surgical Oncology. Elsevier BV; 2019; 45:2009-2015 10.1016/j.ejso.2019.06.007
• Body weight changes in young breast cancer survivors and associated predictors. Cite
  Sella T, Tan-Wasielewski Z, Rosenberg SM, Poorvu PD, Ruddy KJ, Gelber SI, et al. Body weight changes in young breast cancer survivors and associated predictors.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:11574-11574 10.1200/jco.2019.37.15_suppl.11574
• Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USA Cite
  Franzoi MA, Schwartsmann G, de Azevedo SJ, Geib G, Zaffaroni F, Liedke PER. Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USA. Journal of Racial and Ethnic Health Disparities. Springer Science and Business Media LLC; 2019; 6:909-916 10.1007/s40615-019-00591-y
• Subsequent Breast Cancer in Female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE) Cite
  Ehrhardt MJ, Howell CR, Hale K, Baassiri MJ, Rodriguez C, Wilson CL, et al. Subsequent Breast Cancer in Female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:1647-1656 10.1200/jco.18.01099
• Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer Cite
  Chen H, Zhang P, Zhang M, Wang M, Bai F, Wu K. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer. Journal of Surgical Research. Elsevier BV; 2019; 239:224-232 10.1016/j.jss.2019.02.002
• Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer Cite
  Ogiya R, Sagara Y, Niikura N, Freedman RA. Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2019; 19:200-207.e1 10.1016/j.clbc.2019.01.005
• The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients Cite
  Gregorowitsch ML, Ghedri A, Young-Afat DA, Bijlsma R, Baas IO, van Schaik-van de Mheen C, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 175:429-441 10.1007/s10549-019-05149-4
• Abstract P2-08-07: Prognostic impact of the 21-gene recurrence score assay among young women with node-negative and node-positive ER+/HER2- breast cancer Cite
  Poorvu P, Gelber S, Rosenberg S, Ruddy K, Tamimi R, Collins L, et al. Abstract P2-08-07: Prognostic impact of the 21-gene recurrence score assay among young women with node-negative and node-positive ER+/HER2- breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p2-08-07
• Women’s occupational exposure to polycyclic aromatic hydrocarbons and risk of breast cancer Cite
  Lee DG, Burstyn I, Lai AS, Grundy A, Friesen MC, Aronson KJ, et al. Women’s occupational exposure to polycyclic aromatic hydrocarbons and risk of breast cancer. Occupational and Environmental Medicine. BMJ; 2018; 76:22-29 10.1136/oemed-2018-105261
• Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40–44 years Cite
  Hironaka-Mitsuhashi A, Tsuda H, Yoshida M, Shimizu C, Asaga S, Hojo T, et al. Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40–44 years. Breast Cancer. Springer Science and Business Media LLC; 2018; 26:386-396 10.1007/s12282-018-00937-0
• Breast Cancer Risk After Recent Childbirth Cite
  Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, et al. Breast Cancer Risk After Recent Childbirth. Annals of Internal Medicine. American College of Physicians; 2018; 170:22 10.7326/m18-1323
• Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study Cite
  Liu Z, Sahli Z, Wang Y, Wolff AC, Cope LM, Umbricht CB. Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:689-702 10.1007/s10549-018-4950-4
• Modifiable Risk Factors for the Development of Breast Cancer in Young Women Cite
  Cathcart-Rake EJ, Ruddy KJ, Johnson RH. Modifiable Risk Factors for the Development of Breast Cancer in Young Women. The Cancer Journal. Ovid Technologies (Wolters Kluwer Health); 2018; 24:275-284 10.1097/ppo.0000000000000340
• Clinical Outcomes of Stage I to III Triple-Negative Breast Carcinoma in Young Women Cite
  Ibrahim S, Arjunan A. Clinical Outcomes of Stage I to III Triple-Negative Breast Carcinoma in Young Women. Journal of Global Oncology. American Society of Clinical Oncology (ASCO); 2018; 4:18s-18s 10.1200/jgo.18.10210
• Breast Cancer Mortality in Older and Younger Patients in California Cite
  Tao L, Schwab RB, San Miguel Y, Gomez SL, Canchola AJ, Gago-Dominguez M, et al. Breast Cancer Mortality in Older and Younger Patients in California. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2018; 28:303-310 10.1158/1055-9965.epi-18-0353
• Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women Cite
  Yoon TI, Kwak BS, Yi OV, Kim S, Um E, Yun KW, et al. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 173:657-665 10.1007/s10549-018-5031-4
• Risk factors for loco-regional recurrence after breast conserving surgery: impact of young age and surgical margin status in breast cancer patients Cite
  Vasigh M, Rahmani S, Omranipour R, Haghighat S, Olfatbakhsh E, Kenari AY. Risk factors for loco-regional recurrence after breast conserving surgery: impact of young age and surgical margin status in breast cancer patients. International Surgery Journal. Medip Academy; 2018; 5:2952 10.18203/2349-2902.isj20183713
• Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile Cite
  Takahashi S, Thike AA, Koh VCY, Sasano H, Tan PH. Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile. Virchows Archiv. Springer Science and Business Media LLC; 2018; 473:275-283 10.1007/s00428-018-2416-z
• Outcomes Following Neoadjuvant Chemotherapy for Breast Cancer in Women Aged 40 Years and Younger: Impact of Pathologic Nodal Response Cite
  Kozak MM, Jacobson CE, von Eyben R, Pollom EL, Telli M, Horst KC. Outcomes Following Neoadjuvant Chemotherapy for Breast Cancer in Women Aged 40 Years and Younger: Impact of Pathologic Nodal Response. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2018; 16:845-850 10.6004/jnccn.2018.7022
• Predictors of surveillance mammography outcomes in women with a personal history of breast cancer Cite
  Lowry KP, Braunstein LZ, Economopoulos KP, Salama L, Lehman CD, Gazelle GS, et al. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:209-215 10.1007/s10549-018-4808-9
• Evaluation of recurrence patterns and survival in modern series of young women with breast cancer Cite
  Larson KE, Grobmyer SR, Valente SA. Evaluation of recurrence patterns and survival in modern series of young women with breast cancer. The Breast Journal. Wiley; 2018; 24:749-754 10.1111/tbj.13041
• Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study Cite
  Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, et al. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1513-1520 10.1200/jco.2017.77.3424
• 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study Cite
  Ploquin A, Pistilli B, Tresch E, Frenel J, Lerebours F, Lesur A, et al. 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study. European Journal of Cancer. Elsevier BV; 2018; 95:30-37 10.1016/j.ejca.2018.02.030
• Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history Cite
  Engel C, Rhiem K, Hahnen E, Loibl S, Weber KE, Seiler S, et al. Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4029-y
• Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry Cite
  Jones T, Duquette D, Underhill M, Ming C, Mendelsohn-Victor KE, Anderson B, et al. Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:141-152 10.1007/s10549-018-4674-5
• Fertility preservation in BRCA-mutated women: when and how? Cite
  Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how?. Future Oncology. Future Medicine Ltd; 2018; 14:483-490 10.2217/fon-2017-0415
• Analysis of breast cancer in young women in the Department of Defense (DOD) database Cite
  Zimmer AS, Zhu K, Steeg PS, Wu A, Gatti-Mays ME, Soltani S, et al. Analysis of breast cancer in young women in the Department of Defense (DOD) database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:501-511 10.1007/s10549-017-4615-8
• Live birth outcomes after adolescent and young adult breast cancer Cite
  Anderson C, Engel SM, Anders CK, Nichols HB. Live birth outcomes after adolescent and young adult breast cancer. International Journal of Cancer. Wiley; 2018; 142:1994-2002 10.1002/ijc.31227
• Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer Cite
  Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, et al. Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2017; 15:1216-1223 10.6004/jnccn.2017.0158
• Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status Cite
  Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G, et al. Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 110:426-429 10.1093/jnci/djx206
• Young Women Who Achieve Pathologic Complete Response in the Axillary Lymph Nodes Do Not Have Improved Survival Compared to Those Who Remain Lymph Node Positive after Neoadjuvant Chemotherapy Cite
  Kozak M, Jacobson C, Horst K. Young Women Who Achieve Pathologic Complete Response in the Axillary Lymph Nodes Do Not Have Improved Survival Compared to Those Who Remain Lymph Node Positive after Neoadjuvant Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017; 99:E26 10.1016/j.ijrobp.2017.06.653
• A Young Female Athlete With Acute Low Back Pain Caused by Stage IV Breast Cancer Cite
  Kahn EA. A Young Female Athlete With Acute Low Back Pain Caused by Stage IV Breast Cancer. Journal of Chiropractic Medicine. Elsevier BV; 2017; 16:230-235 10.1016/j.jcm.2017.06.002
• The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer Cite
  Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P, et al. The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer. Scientific Reports. Springer Science and Business Media LLC; 2017; 7 10.1038/s41598-017-10414-x
• Breast cancer in young women and prognosis: How important are proliferation markers? Cite
  Fredholm H, Magnusson K, Lindström LS, Tobin NP, Lindman H, Bergh J, et al. Breast cancer in young women and prognosis: How important are proliferation markers?. European Journal of Cancer. Elsevier BV; 2017; 84:278-289 10.1016/j.ejca.2017.07.044
• Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ Cite
  Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ. Clinical Breast Cancer. Elsevier BV; 2018; 18:e179-e185 10.1016/j.clbc.2017.08.001
• Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery Cite
  Botteri E, Veronesi P, Vila J, Rotmensz N, Galimberti V, Thomazini MV, et al. Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery. British Journal of Surgery. Wiley; 2017; 104:1802-1810 10.1002/bjs.10658
• Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy Cite
  Yeo W, Mo FKF, Pang E, Suen JJS, Koh J, Loong HHF, et al. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. BMC Women's Health. Springer Science and Business Media LLC; 2017; 17 10.1186/s12905-017-0409-8
• The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy Cite
  Alabdulkareem H, Pinchinat T, Khan S, Landers A, Christos P, Simmons R, et al. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. The Breast Journal. Wiley; 2017; 24:148-153 10.1111/tbj.12853
• Patterns and predictors of first and subsequent recurrence in women with early breast cancer Cite
  Geurts YM, Witteveen A, Bretveld R, Poortmans PM, Sonke GS, Strobbe LJA, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:709-720 10.1007/s10549-017-4340-3
• Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure Cite
  Ramchand SK, Seeman E, Wang X, Ghasem-Zadeh A, Francis PA, Ponnusamy EJ, et al. Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure. Bone. Elsevier BV; 2017; 103:131-135 10.1016/j.bone.2017.06.024
• Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide Cite
  Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, et al. Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLOS Medicine. Public Library of Science (PLoS); 2017; 14:e1002335 10.1371/journal.pmed.1002335
• Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials Cite
  Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, et al. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:3113-3122 10.1200/jco.2016.72.0946
• Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer Cite
  Maishman T, Cutress RI, Hernandez A, Gerty S, Copson ER, Durcan L, et al. Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2017; 266:165-172 10.1097/sla.0000000000001930
• The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients Cite
  Sopik V, Sun P, Narod SA. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:391-402 10.1007/s10549-017-4333-2
• How Young Is Too Young in Breast Cancer?—Young Breast Cancer Is Not a Unique Biological Subtype Cite
  Fu J, Wu L, Fu W, Tan Y, Xu T, Hong Z, et al. How Young Is Too Young in Breast Cancer?—Young Breast Cancer Is Not a Unique Biological Subtype. Clinical Breast Cancer. Elsevier BV; 2018; 18:e25-e39 10.1016/j.clbc.2017.05.015
• Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer Cite
  Koga C, Akiyoshi S, Ishida M, Nakamura Y, Ohno S, Tokunaga E. Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer. Springer Science and Business Media LLC; 2017; 24:714-719 10.1007/s12282-017-0764-1
• Survivorship workshop delivery to primary care providers. Cite
  Chaput G, Hendricks K, D'Souza V, Khan S, Naismith L. Survivorship workshop delivery to primary care providers.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2-2 10.1200/jco.2016.34.3_suppl.2
• Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy Cite
  Fréour T, Barrière P, Masson D. Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy. European Journal of Cancer. Elsevier BV; 2017; 74:1-8 10.1016/j.ejca.2016.12.008
• Impact of lifestyle and psychological stress on the development of early onset breast cancer Cite
  Li P, Huang J, Wu H, Fu C, Li Y, Qiu J. Impact of lifestyle and psychological stress on the development of early onset breast cancer. Medicine. Ovid Technologies (Wolters Kluwer Health); 2016; 95:e5529 10.1097/md.0000000000005529
• Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database Cite
  Chen H, Zhou M, Tian W, Meng K, He H. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0165409 10.1371/journal.pone.0165409
• Early onset breast cancer in Ashkenazi women carriers of founderBRCA1/2mutations: beyond 10 years of follow-up Cite
  Dagan E, Gershoni-Baruch R, Kurolap A, Fried G. Early onset breast cancer in Ashkenazi women carriers of founderBRCA1/2mutations: beyond 10 years of follow-up. European Journal of Cancer Care. Wiley; 2016; 26:e12594 10.1111/ecc.12594
• Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis Cite
  Silva C, Caramelo O, Almeida-Santos T, Ribeiro Rama AC. Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis. Human Reproduction. Oxford University Press (OUP); 2016; 31:2737-2749 10.1093/humrep/dew224
• Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial Cite
  Vrieling C, van Werkhoven E, Maingon P, Poortmans P, Weltens C, Fourquet A, et al. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial. JAMA Oncology. American Medical Association (AMA); 2017; 3:42 10.1001/jamaoncol.2016.3031
• Long-term outcome in young women with breast cancer: a population-based study Cite
  Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 160:131-143 10.1007/s10549-016-3983-9
• Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes Cite
  Kim S, Chun M, Han S, Jung YS, Choi JH, Kang SY, et al. Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes. Cancer Research and Treatment. Korean Cancer Association; 2017; 49:484-493 10.4143/crt.2016.246
• Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger Cite
  Plichta JK, Rai U, Tang R, Coopey SB, Buckley JM, Gadd MA, et al. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 23:3212-3220 10.1245/s10434-016-5404-z
• The association of age with breast cancer mortality within four race/ethnicities for the triple negative and HER2-overexpressing subtypes. Cite
  Parise C, Caggiano V. The association of age with breast cancer mortality within four race/ethnicities for the triple negative and HER2-overexpressing subtypes.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:1073-1073 10.1200/jco.2016.34.15_suppl.1073
• Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients Cite
  Laurberg T, Lyngholm CD, Christiansen P, Alsner J, Overgaard J. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients. Radiotherapy and Oncology. Elsevier BV; 2016; 120:98-106 10.1016/j.radonc.2016.05.006
• Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer Cite
  Qiu L, Fu F, Huang M, Lin Y, chen Y, Chen M, et al. Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep26627
• Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy Cite
  Villarreal-Garza C, Bargallo-Rocha JE, Soto-Perez-de-Celis E, Lasa-Gonsebatt F, Arce-Salinas C, Lara-Medina F, et al. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 157:385-394 10.1007/s10549-016-3811-2
• A Rosier Picture for Young Women With Breast Cancer Cite
  Warner E. A Rosier Picture for Young Women With Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2079-2081 10.1200/jco.2016.66.6073
• Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base Cite
  Jacob JD, Hodge C, Franko J, Pezzi CM, Goldman CD, Klimberg VS. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. Journal of Surgical Oncology. Wiley; 2016; 113:721-725 10.1002/jso.24241
• Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study Cite
  Wang K, Ren Y, Li H, Zheng K, Jiang J, Zou T, et al. Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0152312 10.1371/journal.pone.0152312
• Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer Cite
  Aalders KC, Postma EL, Strobbe LJ, van der Heiden-van der Loo M, Sonke GS, Boersma LJ, et al. Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2107-2114 10.1200/jco.2015.64.3536
• Abstract P4-11-05: Safety of fertility preservation indicated by a diagnosis of breast cancer: A Swedish registry-matched cohort study Cite
  Rodriguez-Wallberg K, Eloranta S, Krawiec K, Lissmats A, Liljegren A. Abstract P4-11-05: Safety of fertility preservation indicated by a diagnosis of breast cancer: A Swedish registry-matched cohort study. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p4-11-05
• No strong evidence for increased risk of breast cancer 8–26 years after multiple mammograms in their 30s in females at moderate and high familial risk Cite
  Evans DG, Kotre CJ, Harkness E, Wilson M, Maxwell AJ, Howell A. No strong evidence for increased risk of breast cancer 8–26 years after multiple mammograms in their 30s in females at moderate and high familial risk. The British Journal of Radiology. British Institute of Radiology; 2016; 89:20150960 10.1259/bjr.20150960
• Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy Cite
  Bellet M, Gray KP, Francis PA, Láng I, Ciruelos E, Lluch A, et al. Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:1584-1593 10.1200/jco.2015.61.2259
• Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis Cite
  Ryser MD, Worni M, Turner EL, Marks JR, Durrett R, Hwang ES. Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis. Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 108:djv372 10.1093/jnci/djv372
• Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years) Cite
  Zhang Z, Han Y, Nian Q, Chen G, Cui S, Wang X. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years). PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0144376 10.1371/journal.pone.0144376
• Survival in familial and non-familial breast cancer by age and stage at diagnosis Cite
  Kharazmi E, Försti A, Sundquist K, Hemminki K. Survival in familial and non-familial breast cancer by age and stage at diagnosis. European Journal of Cancer. Elsevier BV; 2016; 52:10-18 10.1016/j.ejca.2015.09.015
• Pregnancy history and risk of premenopausal breast cancer—a nested case-control study Cite
  Hajiebrahimi M, Cnattingius S, Lambe M, Bahmanyar S. Pregnancy history and risk of premenopausal breast cancer—a nested case-control study. International Journal of Epidemiology. Oxford University Press (OUP); 2015; 45:816-824 10.1093/ije/dyv293
• The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis Cite
  Liu J, Chen K, Mao K, Su F, Liu Q, Jacobs LK. The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis. Oncotarget. Impact Journals, LLC; 2015; 7:6063-6073 10.18632/oncotarget.5844
• Breast cancer age at diagnosis patterns in four Latin American Populations: A comparison with North American countries Cite
  Franco-Marina F, López-Carrillo L, Keating NL, Arreola-Ornelas H, Marie Knaul F. Breast cancer age at diagnosis patterns in four Latin American Populations: A comparison with North American countries. Cancer Epidemiology. Elsevier BV; 2015; 39:831-837 10.1016/j.canep.2015.10.004
• Breast Cancer in Women of Younger than 35 Years: A Single Center Study Cite
  Das U, KC L. Breast Cancer in Women of Younger than 35 Years: A Single Center Study. Journal of Molecular Biomarkers & Diagnosis. OMICS Publishing Group; 2015; 06 10.4172/2155-9929.1000261
• The effect of age in breast conserving therapy: A retrospective analysis on pathology and clinical outcome data Cite
  Chen W, Sonke J, Stroom J, Bartelink H, Verheij M, Gilhuijs K. The effect of age in breast conserving therapy: A retrospective analysis on pathology and clinical outcome data. Radiotherapy and Oncology. Elsevier BV; 2015; 114:314-321 10.1016/j.radonc.2015.01.010
• The Effect of Young Age in Hormone Receptor Positive Breast Cancer Cite
  Lee MK, Varzi LA, Chung DU, Cao M, Gornbein J, Apple SK, et al. The Effect of Young Age in Hormone Receptor Positive Breast Cancer. BioMed Research International. Hindawi Limited; 2015; 2015:1-6 10.1155/2015/325715
• Abstract 855: History of oral contraceptive use in breast cancer patients and risk for early breast cancer events Cite
  Huzell L, Persson M, Simonsson M, Markkula A, Ingvar C, Rose C, et al. Abstract 855: History of oral contraceptive use in breast cancer patients and risk for early breast cancer events. Epidemiology. American Association for Cancer Research; 2015; 10.1158/1538-7445.am2015-855
• United States Health Policies and Late-stage Breast and colorectal cancer diagnosis: Why such disparities by age? Cite
  Mobley LR, Kuo T. United States Health Policies and Late-stage Breast and colorectal cancer diagnosis: Why such disparities by age?. Health Economics Review. Springer Science and Business Media LLC; 2015; 5 10.1186/s13561-015-0058-2
• Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study Cite
  Chang C, Chen S, Liu C. Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0130725 10.1371/journal.pone.0130725
• Breast cancer in very young women: Clinicopathological study of 149 patients ≤25 years old Cite
  de Deus Moura R, Carvalho FM, Bacchi CE. Breast cancer in very young women: Clinicopathological study of 149 patients ≤25 years old. The Breast. Elsevier BV; 2015; 24:461-467 10.1016/j.breast.2015.04.002
• Prognostic effect of menstrual cycle on timing of surgery in premenopausal breast cancer patients Cite
  Liu Y, Wang Y, Zhou L, Yin K, Yin W, Lu J. Prognostic effect of menstrual cycle on timing of surgery in premenopausal breast cancer patients. The American Journal of Surgery. Elsevier BV; 2015; 210:506-511 10.1016/j.amjsurg.2015.01.025
• Abstract P4-14-06: Characteristics of benign breast disease and subsequent risk of breast cancer differ by age among African Americans Cite
  Cote ML, Ruterbusch JJ, Bandyopadhyay S, Ahmed Q, Alosh B, Abdulfatah E, et al. Abstract P4-14-06: Characteristics of benign breast disease and subsequent risk of breast cancer differ by age among African Americans. Poster Session Abstracts. American Association for Cancer Research; 2015; 10.1158/1538-7445.sabcs14-p4-14-06
• Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients Cite
  Bick U. Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients. Breast Care. S. Karger AG; 2015; 10:13-20 10.1159/000375390
• Hormone Therapy and Young-Onset Breast Cancer Cite
  O'Brien KM, Fei C, Sandler DP, Nichols HB, DeRoo LA, Weinberg CR. Hormone Therapy and Young-Onset Breast Cancer. American Journal of Epidemiology. Oxford University Press (OUP); 2015; 181:799-807 10.1093/aje/kwu347
• History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response Cite
  Huzell L, Persson M, Simonsson M, Markkula A, Ingvar C, Rose C, et al. History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 149:505-515 10.1007/s10549-014-3252-8
• Habitual sleep–wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: A longitudinal study Cite
  Hsiao F, Kuo W, Jow G, Chang K, Yang P, Lam H, et al. Habitual sleep–wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: A longitudinal study. Psychoneuroendocrinology. Elsevier BV; 2015; 53:60-68 10.1016/j.psyneuen.2014.12.014
• Breast cancer in younger women in Switzerland 1996–2009: A longitudinal population-based study Cite
  Bodmer A, Feller A, Bordoni A, Bouchardy C, Dehler S, Ess S, et al. Breast cancer in younger women in Switzerland 1996–2009: A longitudinal population-based study. The Breast. Elsevier BV; 2015; 24:112-117 10.1016/j.breast.2014.11.004
• US breast cancer mortality trends in young women according to race Cite
  Ademuyiwa FO, Gao F, Hao L, Morgensztern D, Aft RL, Ma CX, et al. US breast cancer mortality trends in young women according to race. Cancer. Wiley; 2014; 121:1469-1476 10.1002/cncr.29178
• Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less Cite
  Bayraktar S, Amendola L, Gutierrez-Barrera AM, Hashmi SS, Amos C, Gambello M, et al. Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less. The Breast. Elsevier BV; 2014; 23:770-774 10.1016/j.breast.2014.08.010
• Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? Cite
  Sheridan W, Scott T, Caroline S, Yvonne Z, Vanessa B, David V, et al. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 147:617-629 10.1007/s10549-014-3125-1
• Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort Cite
  Cao JQ, Truong PT, Olivotto IA, Olson R, Coulombe G, Keyes M, et al. Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014; 90:509-517 10.1016/j.ijrobp.2014.06.041
• Bra Wearing Not Associated with Breast Cancer Risk: A Population-Based Case–Control Study Cite
  Chen L, Malone KE, Li CI. Bra Wearing Not Associated with Breast Cancer Risk: A Population-Based Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:2181-2185 10.1158/1055-9965.epi-14-0414
• Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer Cite
  Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, et al. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:2010-2017 10.1200/jco.2013.49.3676
• Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women Cite
  Beaber EF, Malone KE, Tang MC, Barlow WE, Porter PL, Daling JR, et al. Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:755-764 10.1158/1055-9965.epi-13-0944
• First international consensus guidelines for breast cancer in young women (BCY1) Cite
  Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA, et al. First international consensus guidelines for breast cancer in young women (BCY1). The Breast. Elsevier BV; 2014; 23:209-220 10.1016/j.breast.2014.03.011
• Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity Cite
  Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity. The American Journal of Cardiology. Elsevier BV; 2013; 112:1980-1984 10.1016/j.amjcard.2013.08.026
• Effectiveness of routine follow-up in the detection of contralateral breast cancer in young women with early breast cancer Cite
  Koedijk M, van der Sangen M, Poortmans P, van Mierlo-Jansen P, van den Broek W, Storck B, et al. Effectiveness of routine follow-up in the detection of contralateral breast cancer in young women with early breast cancer. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2013; 39:1186-1191 10.1016/j.ejso.2013.08.031
• Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk Cite
  Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, et al. Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:1571-1578 10.1093/jnci/djt213
• Long-Term Impact of Young Age at Diagnosis on Treatment Outcome and Patterns of Failure in Patients with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy Cite
  Vicini FA, Shaitelman S, Wilkinson JB, Shah C, Ye H, Kestin LL, et al. Long-Term Impact of Young Age at Diagnosis on Treatment Outcome and Patterns of Failure in Patients with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy. The Breast Journal. Wiley; 2013; 19:365-373 10.1111/tbj.12127
• A link between premenopausal iron deficiency and breast cancer malignancy Cite
  Jian J, Yang Q, Shao Y, Axelrod D, Smith J, Singh B, et al. A link between premenopausal iron deficiency and breast cancer malignancy. BMC Cancer. Springer Science and Business Media LLC; 2013; 13 10.1186/1471-2407-13-307
• Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer Cite
  Bell RJ, Fradkin P, Parathithasan N, Robinson PJ, Schwarz M, Davis SR. Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer. The Breast. Elsevier BV; 2013; 22:980-985 10.1016/j.breast.2013.05.013
• Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study Cite
  Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, et al. Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:978-988 10.1093/jnci/djt134
• Dairy Intakes in Older Girls and Risk of Benign Breast Disease in Young Women Cite
  Berkey CS, Willett WC, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Dairy Intakes in Older Girls and Risk of Benign Breast Disease in Young Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2013; 22:670-674 10.1158/1055-9965.epi-12-1133
• Proven non-carriers in BRCA families have an earlier age of onset of breast cancer Cite
  Vos JR, de Bock GH, Teixeira N, van der Kolk DM, Jansen L, Mourits MJ, et al. Proven non-carriers in BRCA families have an earlier age of onset of breast cancer. European Journal of Cancer. Elsevier BV; 2013; 49:2101-2106 10.1016/j.ejca.2013.02.018
• Active Smoking and Breast Cancer Risk: Original Cohort Data and Meta-Analysis Cite
  Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ. Active Smoking and Breast Cancer Risk: Original Cohort Data and Meta-Analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:515-525 10.1093/jnci/djt023
• The Effect of Age on Race-Related Breast Cancer Survival Disparities Cite
  Wray CJ, Phatak UR, Robinson EK, Wiatek RL, Rieber AG, Gonzalez A, et al. The Effect of Age on Race-Related Breast Cancer Survival Disparities. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2013; 20:2541-2547 10.1245/s10434-013-2913-x
• Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study Cite
  Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, et al. Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2013; 31:433-439 10.1200/jco.2012.43.2013
• Epstein-Barr Virus, Human Papillomavirus and Mouse Mammary Tumour Virus as Multiple Viruses in Breast Cancer Cite
  Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein-Barr Virus, Human Papillomavirus and Mouse Mammary Tumour Virus as Multiple Viruses in Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e48788 10.1371/journal.pone.0048788
• Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection Cite
  Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, et al. Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2012; 256:428-436 10.1097/sla.0b013e3182654494
• Patients younger than 40years old and older than 70years old affected by ER(−)/PR(−)/HER2(−) breast cancer have low survival rates: Results of a mono-institutional retrospective analysis Cite
  Sanpaolo P, Barbieri V, Genovesi D, Fusco V, Ausili Cèfaro G, Audisio RA. Patients younger than 40years old and older than 70years old affected by ER(−)/PR(−)/HER2(−) breast cancer have low survival rates: Results of a mono-institutional retrospective analysis. Journal of Geriatric Oncology. Elsevier BV; 2012; 3:312-319 10.1016/j.jgo.2012.06.001
• Fertility Drugs and Young-Onset Breast Cancer: Results From the Two Sister Study Cite
  Fei C, DeRoo LA, Sandler DP, Weinberg CR. Fertility Drugs and Young-Onset Breast Cancer: Results From the Two Sister Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:1021-1027 10.1093/jnci/djs255
• Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover Cite
  Clarke CA, Keegan THM, Yang J, Press DJ, Kurian AW, Patel AH, et al. Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:1094-1101 10.1093/jnci/djs264
• Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report Cite
  Karlsson P, Cole B, Chua B, Price K, Lindtner J, Collins J, et al. Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report. Annals of Oncology. Elsevier BV; 2012; 23:2852-2858 10.1093/annonc/mds118
• Biology, Treatment, and Outcome in Very Young and Older Women with DCIS Cite
  Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, et al. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:3777-3784 10.1245/s10434-012-2413-4
• Risk of Primary Non–Breast Cancer After Female Breast Cancer by Age at Diagnosis Cite
  Mellemkjær L, Christensen J, Frederiksen K, Pukkala E, Weiderpass E, Bray F, et al. Risk of Primary Non–Breast Cancer After Female Breast Cancer by Age at Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 20:1784-1792 10.1158/1055-9965.epi-11-0009
• Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan Cite
  Lee K, Chen S, Chan CH, Lu C, Chen C, Lin J, et al. Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:2647-2655 10.1158/1055-9965.epi-08-0109
• Reproductive Status at First Diagnosis Influences Risk of Radiation-Induced Second Primary Contralateral Breast Cancer in the WECARE Study Cite
  Brooks JD, Boice JD, Stovall M, Reiner AS, Bernstein L, John EM, et al. Reproductive Status at First Diagnosis Influences Risk of Radiation-Induced Second Primary Contralateral Breast Cancer in the WECARE Study. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 84:917-924 10.1016/j.ijrobp.2012.01.047
• Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens Cite
  Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, et al. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 120:245-251 10.1007/s10549-009-0426-x
• Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer Cite
  Swain SM, Jeong J, Geyer CE, Costantino JP, Pajon ER, Fehrenbacher L, et al. Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2010; 362:2053-2065 10.1056/nejmoa0909638
• Family history and risk of breast cancer: nurses’ health study Cite
  Colditz GA, Kaphingst KA, Hankinson SE, Rosner B. Family history and risk of breast cancer: nurses’ health study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 133:1097-1104 10.1007/s10549-012-1985-9
• Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China Cite
  Zhang L, Hao C, Dong G, Tong Z. Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China. Breast Care. S. Karger AG; 2012; 7:13-17 10.1159/000336539
• Correlation of Age at Oral Contraceptive Pill Start with Age at Breast Cancer Diagnosis Cite
  Imkampe A, Bates T. Correlation of Age at Oral Contraceptive Pill Start with Age at Breast Cancer Diagnosis. The Breast Journal. Wiley; 2011; 18:35-40 10.1111/j.1524-4741.2011.01181.x
• Young women with family history of breast cancer and their risk factors for benign breast disease Cite
  Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. Wiley; 2011; 118:2796-2803 10.1002/cncr.26519
• Faculty Opinions recommendation of Improvement in breast cancer outcomes over time: are older women missing out? Cite
  Wildiers H. Faculty Opinions recommendation of Improvement in breast cancer outcomes over time: are older women missing out?. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. Faculty Opinions Ltd; 2012; 10.3410/f.14267132.15779274
• Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk Cite
  Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk. JAMA. American Medical Association (AMA); 2011; 306:1884 10.1001/jama.2011.1590
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy Cite
  Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:3885-3891 10.1200/jco.2011.36.1105
• Adolescent intakes of alcohol and folate and risk of proliferative benign breast disease. Cite
  Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, et al. Adolescent intakes of alcohol and folate and risk of proliferative benign breast disease.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:169-169 10.1200/jco.2011.29.27_suppl.169
• Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Cite
  Buckley JM, Coopey S, Samphao S, Specht MC, Hughes KS, Gadd M, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:70-70 10.1200/jco.2011.29.27_suppl.70
• Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study Cite
  Peng R, Wang S, Shi Y, Liu D, Teng X, Qin T, et al. Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study. The Breast. Elsevier BV; 2011; 20:568-573 10.1016/j.breast.2011.07.012
• Triple-negative breast cancer in Hispanic patients Cite
  Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D, Blake-Cerda M, Arce C, Motola-Kuba D, et al. Triple-negative breast cancer in Hispanic patients. Cancer. Wiley; 2011; 117:3658-3669 10.1002/cncr.25961
• Cigarette Smoking and the Incidence of Breast Cancer Cite
  Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. Cigarette Smoking and the Incidence of Breast Cancer. Archives of Internal Medicine. American Medical Association (AMA); 2011; 171 10.1001/archinternmed.2010.503
• Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast Cite
  Biglia N, Bounous V, Martincich L, Panuccio E, Liberale V, Ottino L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:199-204 10.1016/j.ejso.2010.12.011
• Higher population-based incidence rates of triple-negative breast cancer among young African-American women Cite
  Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women. Cancer. Wiley; 2011; 117:2747-2753 10.1002/cncr.25862
• Long-term observational follow-up study of breast cancer diagnosed in women ≤40 years old Cite
  Karihtala P, Winqvist R, Bloigu R, Jukkola-Vuorinen A. Long-term observational follow-up study of breast cancer diagnosed in women ≤40 years old. The Breast. Elsevier BV; 2010; 19:456-461 10.1016/j.breast.2010.05.001
• Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women Cite
  Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, et al. Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:2496-2502 10.1158/1055-9965.epi-10-0747
• Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations Cite
  Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, et al. Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 103:1103-1108 10.1038/sj.bjc.6605876
• Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy Cite
  Dores GM, Anderson WF, Beane Freeman LE, Fraumeni JF, Curtis RE. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 103:1081-1084 10.1038/sj.bjc.6605877
• History of Smoking is Associated with Younger Age at Diagnosis of Breast Cancer Cite
  Abramowitz MC, Li T, Morrow M, Anderson PR, Bleicher RJ, Goldstein LJ, et al. History of Smoking is Associated with Younger Age at Diagnosis of Breast Cancer. The Breast Journal. Wiley; 2010; 10.1111/j.1524-4741.2010.00921.x
• Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years Cite
  van der Sangen MJC, van de Wiel FMM, Poortmans PMP, Tjan-Heijnen VCG, Nieuwenhuijzen GAP, Roumen RMH, et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:207-215 10.1007/s10549-010-1110-x
• The impact of young age on breast cancer outcome Cite
  Livi L, Meattini I, Saieva C, Borghesi S, Scotti V, Petrucci A, et al. The impact of young age on breast cancer outcome. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2010; 36:639-645 10.1016/j.ejso.2010.05.016
• Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer Cite
  Ellberg C, Olsson H. Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer. BMC Cancer. Springer Science and Business Media LLC; 2011; 11 10.1186/1471-2407-11-497
• Determination of clear margin in breast-conserving surgery: Is 1 mm needed? Cite
  Geffrelot J, Toudic Emily F, Levy C, Blanc Fournier C, Segura C, Switsers O, et al. Determination of clear margin in breast-conserving surgery: Is 1 mm needed?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:515-515 10.1200/jco.2010.28.15_suppl.515
• The prognostic impact of age in patients with triple-negative breast cancer Cite
  Liedtke C, Hess KR, Karn T, Rody A, Kiesel L, Hortobagyi GN, et al. The prognostic impact of age in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 138:591-599 10.1007/s10549-013-2461-x
• Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation Cite
  Chen J, Nie K, Bahri S, Hsu C, Hsu F, Shih H, et al. Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation. Radiology. Radiological Society of North America (RSNA); 2010; 255:44-52 10.1148/radiol.09091090
• Prospective Study of Adolescent Alcohol Consumption and Risk of Benign Breast Disease in Young Women Cite
  Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Rockett HRH, et al. Prospective Study of Adolescent Alcohol Consumption and Risk of Benign Breast Disease in Young Women. PEDIATRICS. American Academy of Pediatrics (AAP); 2010; 125:e1081-e1087 10.1542/peds.2009-2347
• Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients Cite
  Bedrosian I, Hu C, Chang GJ. Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:401-409 10.1093/jnci/djq018
• Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland Cite
  McAree B, O'Donnell M, Spence A, Lioe T, McManus D, Spence R. Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland. The Breast. Elsevier BV; 2010; 19:97-104 10.1016/j.breast.2009.12.002
• Some characteristics of familial breast cancer Cite
  Anderson DE. Some characteristics of familial breast cancer. Cancer. Wiley; 1971; 28:1500-1504 10.1002/1097-0142(197112)28:6<1500::aid-cncr2820280623>3.0.co;2-d
• Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes Cite
  Rimawi MF, Shetty PB, Weiss HL, Schiff R, Osborne CK, Chamness GC, et al. Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes. Cancer. Wiley; 2010; 116:1234-1242 10.1002/cncr.24816
• Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years Cite
  Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, et al. Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:1157-1166 10.1158/1055-9965.epi-08-1005
• Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome Cite
  Oh E, Wood PA, Yang X, Hrushesky WJM. Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 118:345-359 10.1007/s10549-008-0253-5
• 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis Cite
  Jansen-van der Weide M, Greuter M, Jansen L, Oosterwijk J, Pijnappel R, Oudkerk M, et al. 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:239 10.1016/s1359-6349(10)70642-x
• General and Abdominal Obesity and Survival among Young Women with Breast Cancer Cite
  Abrahamson PE, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, et al. General and Abdominal Obesity and Survival among Young Women with Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2006; 15:1871-1877 10.1158/1055-9965.epi-06-0356
• Tea Consumption and Risk of Breast Cancer Cite
  Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Tea Consumption and Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:341-345 10.1158/1055-9965.epi-08-0819
• Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age Cite
  Courdi A, Doyen J, Gal J, Chamorey E. Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age. Oncology. S. Karger AG; 2010; 79:349-354 10.1159/000323483
• Effect of Prediagnostic Alcohol Consumption on Survival after Breast Cancer in Young Women Cite
  Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE. Effect of Prediagnostic Alcohol Consumption on Survival after Breast Cancer in Young Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:1988-1996 10.1158/1055-9965.epi-07-2897
• Alcohol intake and breast cancer risk among young women Cite
  Berstad P, Ma H, Bernstein L, Ursin G. Alcohol intake and breast cancer risk among young women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2007; 108:113-120 10.1007/s10549-007-9578-8